In lung adenocarcinoma, UCHL1 combined with clinical lung tumor detection indicators improves the detection rate of lung adenocarcinoma, provides sensitive indicators for the early diagnosis of lung adenocarcinoma, and provides possible targets for the development of targeted drugs for lung adenocarcinoma. This evidence concerns the gene UCHL1 and lung adenocarcinoma.